Gastroduodenal posters

April 2005
Gut;Apr2005 Supplement 2, Vol. 54, pA59
Academic Journal
The article presents information on abstracts related to human biology. An abstract presents information on time trends in hospital admissions and mortality due to peptic ulcer in Scotland during 1991-2002. Despite the recent advent of potent acid suppressants and treatment for H. pylon infection, time trends in hospital admission rates for peptic ulcer (PU) remain unclear. Researchers have previously shown an increase among older people, especially for hemorrhage, over the 1990s in England, although there was little overall change. In contrast, hospitalization rates for PU fell in the U.S. over this period, irrespective of age. To determine time trends in Scotland for hospital admissions and mortality for duodenal ulcer, gastric ulcer, as well as prescriptions for proton pump inhibitors and low dose aspirin, from 1991 to 2002.


Related Articles

  • Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor. Kaneko, Eizo; Hoshihara, Yoshio; Sakaki, Nobuhiro; Harasawa, Shigeru; Ashida, Kiyoshi; Asaka, Masahiro; Asaki, Shigeru; Nakamura, Takashi; Kobayashi, Kenzo; Kajiyama, Goro; Ogawa, Nobuya; Yao, Tsuneyoshi; Muto, Yasutoshi; Nakazawa, Saburo; Takemoto, Tadayoshi; Kaneko, E; Hoshihara, Y; Sakaki, N; Harasawa, S; Ashida, K // Journal of Gastroenterology;2000, Vol. 35 Issue 11, p824 

    We investigated the peptic ulcer recurrence rates during maintenance therapy with H2-receptor antagonists (H2RAs) following first-line therapy with a proton pump inhibitor (PPI). Patients with gastric ulcer (GU) or duodenal ulcer (DU) were enrolled in this study; 583 eligible patients (GU, 325;...

  • Helicobacter pylori Infection and Eradication in Paediatric Patients. Malaty, H.M. // Pediatric Drugs;Sep/Oct2000, Vol. 2 Issue 5, p357 

    Helicobacter pylori is now recognised to be typically acquired during childhood. Studies also indicate that the infection is frequently lost in childhood; however, it is still unclear whether this is related to the use of antibacterials, the natural history of the infection, or both. H. pylori...

  • Test for GERD Reveals That Many Are Taking Medications Unnecessarily.  // Women's Health Advisor;Sep2013, Vol. 17 Issue 9, p5 

    The article focuses on the increased inappropriate use of proton pump inhibitors (PPI) by people without being diagnosed with gastro esophageal reflux disease (GERD). It suggests for early diagnosis of GERD by esophageal power of hydrogen (Ph) monitoring following an endoscopy which helps to...

  • Proton Pump Inhibitors After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding. Mesihovic, Rusmir; Vanis, Nenad; Mehmedovic, Amila; Gornjakovic, Srdjan; Gribajcevic, Mehmed // Medicinski Arhiv;2009, Vol. 63 Issue 6, p323 

    Background: Peptic ulcer bleeding is a common and potentially fatal condition. For patients with bleeding peptic ulcers that display major endoscopic stigmata of recent hemorrhage, a combination of endoscopic and pharmacologic therapy is the current standard management. Objective: To show our...

  • The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2 -receptor antagonist after bleeding from a gastric ulcer. Tatsuo Ozawa, Marisa; Nozomi Yoshikawa, Marisa; Takashige Tomita, Marisa; Yasushi Akita, Marisa; Keiji Mitamura // Journal of Gastroenterology;2003, Vol. 38 Issue 9, p844 

    Background. This study investigated the influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with intravenous infusions of proton pump inhibitors (PPIs) or with H2-receptor antagonists (H[sub2]-RAs) after bleeding from a gastric ulcer. Methods....

  • How Do PPIs Affect Patients with Bleeding Ulcers? Shaughnessy, Allen F. // American Family Physician;8/15/2005, Vol. 72 Issue 4, p683 

    Presents the results of a case study regarding the effectiveness of proton pump inhibitor (PPI) on patients with bleeding peptic ulcers. Factor which enhances platelet function and inhibit fibrolysis in patients with an acute bleeding peptic ulcer; Effect of PPI treatment on mortality rates...

  • H. PYLORI ERADICATION OPTIONS FOR PEPTIC ULCER DISEASE*.  // Monthly Prescribing Reference;Oct2012, Vol. 28 Issue 10, p144 

    A table is presented which classifies several treatments to eradicate Helicobacter pylori bacterium in peptic ulcer disease, including proton pump inhibitor treatments, combination therapy, and H2 receptor antagonist treatments.

  • Rebamipide Contributes to Reducing Adverse Effects of Long-Term Administration of Omeprazole in Rats. Tadashi Hagiwara; Ken-ichi Mukaisho; Zhi-Qiang Ling; Takayo Sakano; Hiroyuki Sugihara; Takanori Hattori // Digestive Diseases & Sciences;Apr2007, Vol. 52 Issue 4, p988 

    Abstract  Proton pump inhibitors (PPIs) have become of great importance for the treatment of peptic ulcer disease and gastroesophageal reflux disease. However, these drugs have several adverse effects, including worsening of corpus atrophic gastritis in patients withH. pyloriinfection,...

  • Continuous Infusion of Pantoprazole versus Ranitidine for Prevention of Ulcer Rebleeding: A U.S. Multicenter Randomized, Double-Blind Study. Jensen, Dennis M.; Pace, Samuel C.; Soffer, Elaine; Comer, Gail M. // American Journal of Gastroenterology;Sep2006, Vol. 101 Issue 9, p1991 

    OBJECTIVES: No North American randomized study has compared ulcer rebleeding rates after endoscopic hemostasis in high-risk patients treated with high-dose intravenous (IV) proton pump inhibitors (PPIs) or IV histamine-2 receptor antagonists. Our hypothesis was that ulcer rebleeding with IV...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics